NZX-listed medicinal cannabis company Rua Bioscience is to raise $3.1 million in new capital to fund the business to a self-sustaining position by the 2026 financial year.
At its annual meeting held virtually today, the board sought shareholder approval to “imminently” issue 37.3 million new
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
